CUTA

gene
On this page

Summary

CUTA (cutA divalent cation tolerance homolog, HGNC:21101) is a protein-coding gene on chromosome 6p21.32, encoding Protein CutA (O60888). May form part of a complex of membrane proteins attached to acetylcholinesterase (AChE).

Enables enzyme binding activity. Involved in protein localization. Located in membrane and mitochondrion.

Source: NCBI Gene 51596 — RefSeq curated summary.

At a glance

  • GWAS associations: 5
  • Clinical variants (ClinVar): 46 total
  • Druggable target: yes
  • MANE Select transcript: NM_001014840

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:21101
Approved symbolCUTA
NamecutA divalent cation tolerance homolog
Location6p21.32
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000112514
Ensembl biotypeprotein_coding
OMIM616953
Entrez51596

Gene structure

Transcript identifiers

Ensembl transcripts: 15 — 9 protein_coding, 4 retained_intron, 2 nonsense_mediated_decay

ENST00000374484, ENST00000374496, ENST00000374500, ENST00000440279, ENST00000462802, ENST00000465956, ENST00000479249, ENST00000482684, ENST00000487637, ENST00000488034, ENST00000488478, ENST00000492510, ENST00000494751, ENST00000607266, ENST00000879000

RefSeq mRNA: 5 — MANE Select: NM_001014840 NM_001014433, NM_001014837, NM_001014838, NM_001014840, NM_015921

CCDS: CCDS34433, CCDS4779

Canonical transcript exons

ENST00000440930 — 0 exons

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 99.40.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 207.7535 / max 754.7523, expressed in 1828 samples.

FANTOM5 promoters (7 alternative TSS)

Promoter IDTPM avgSamples expressed
7316184.12551825
7316451.94521824
7316541.87431818
7316221.16671781
731637.29831734
731590.9390522
731600.4045166

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
pituitary glandUBERON:000000799.40gold quality
adenohypophysisUBERON:000219699.40gold quality
right adrenal gland cortexUBERON:003582799.09gold quality
right adrenal glandUBERON:000123399.08gold quality
left adrenal glandUBERON:000123499.08gold quality
left adrenal gland cortexUBERON:003582599.08gold quality
putamenUBERON:000187498.93gold quality
left lobe of thyroid glandUBERON:000112098.90gold quality
nucleus accumbensUBERON:000188298.90gold quality
right lobe of thyroid glandUBERON:000111998.89gold quality
caudate nucleusUBERON:000187398.84gold quality
stromal cell of endometriumCL:000225598.81gold quality
thyroid glandUBERON:000204698.78gold quality
right uterine tubeUBERON:000130298.75gold quality
C1 segment of cervical spinal cordUBERON:000646998.73gold quality
fundus of stomachUBERON:000116098.71gold quality
prefrontal cortexUBERON:000045198.70gold quality
endocervixUBERON:000045898.70gold quality
hypothalamusUBERON:000189898.70gold quality
primary visual cortexUBERON:000243698.70gold quality
substantia nigraUBERON:000203898.67gold quality
left ovaryUBERON:000211998.67gold quality
right frontal lobeUBERON:000281098.67gold quality
brainUBERON:000095598.64gold quality
cortex of kidneyUBERON:000122598.64gold quality
body of stomachUBERON:000116198.63gold quality
Ammon’s hornUBERON:000195498.63gold quality
dorsolateral prefrontal cortexUBERON:000983498.63gold quality
frontal cortexUBERON:000187098.62gold quality
amygdalaUBERON:000187698.62gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-MTAB-6819yes562.88
E-GEOD-81547no10.56
E-HCAD-31no2.20
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

4 targeting CUTA, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-186-3P99.5166.241685
HSA-MIR-619-3P98.3865.58693
HSA-MIR-6765-3P97.8364.591165
HSA-MIR-483-5P93.5365.81111

Literature-anchored findings (GeneRIF, showing 6)

  • Fluorescence in situ hybridization localizes the gene to chromosome 6p21.32-p21.2. (PMID:10800960)
  • expression profile of CUTA gene in tissues was examined & revealed CUTA gene was constitutively expressed in the 18 tissues tested; CUTA isoform2 was mainly located in mitochondria as a new potential mitochondrial protein (PMID:17924204)
  • H component of CUTA as a novel BACE1-interacting protein that mediates the intracellular trafficking of BACE1 and the processing of APP to Abeta (PMID:22351782)
  • Human CutA1 exhibits remarkably high thermodynamic stability at body temperature should be important for its protein catabolism in the human cells. (PMID:25344844)
  • It mediates APP processing and Abeta generation. (PMID:25557959)
  • Epigenome-wide Association Study Shows Differential DNA Methylation of MDC1, KLF9, and CUTA in Autoimmune Thyroid Disease. (PMID:37962983)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
mus_musculusCutaENSMUSG00000024194
rattus_norvegicusCutaENSRNOG00000000481
drosophila_melanogasterCG11590FBGN0030545
caenorhabditis_elegansWBGENE00009443

Protein

Protein identifiers

Protein CutAO60888 (reviewed: O60888)

Alternative names: Acetylcholinesterase-associated protein, Brain acetylcholinesterase putative membrane anchor

All UniProt accessions (5): O60888, C9IZG4, C9IZQ5, F2Z2Q5, H0YDR4

UniProt curated annotations — full annotation on UniProt →

Function. May form part of a complex of membrane proteins attached to acetylcholinesterase (AChE).

Subunit / interactions. Homotrimer.

Tissue specificity. Ubiquitous. Widely expressed in brain.

Post-translational modifications. O-glycosylated.

Similarity. Belongs to the CutA family.

Isoforms (3)

UniProt IDNamesCanonical?
O60888-1Byes
O60888-2A
O60888-3C

RefSeq proteins (5): NP_001014433, NP_001014837, NP_001014838, NP_001014840, NP_057005 (=MANE)

Domains & families (InterPro)

IDNameType
IPR004323Ion_tolerance_CutAFamily
IPR011322N-reg_PII-like_a/bHomologous_superfamily
IPR015867N-reg_PII/ATP_PRibTrfase_CHomologous_superfamily

Pfam: PF03091

UniProt features (14 total): strand 5, helix 4, splice variant 2, signal peptide 1, chain 1, region of interest 1

Structure

Experimental structures (PDB)

2 structures.

PDBMethodResolution (Å)
2ZFHX-RAY DIFFRACTION2.05
1XK8X-RAY DIFFRACTION2.7

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O60888-F180.160.63

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 176 (showing top): CGGAARNGGCNG_UNKNOWN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, TGACCTY_ERR1_Q2, CAGCTG_AP4_Q5, AACWWCAANK_UNKNOWN, COUP_01, GOBP_RESPONSE_TO_METAL_ION, PATIL_LIVER_CANCER, TCF4_Q5, ATF1_Q6, USF_01, TCF11_01, HNF4_DR1_Q3, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN, HNF4_01

GO Biological Process (2): intracellular protein localization (GO:0008104), response to metal ion (GO:0010038)

GO Molecular Function (3): copper ion binding (GO:0005507), enzyme binding (GO:0019899), protein binding (GO:0005515)

GO Cellular Component (3): mitochondrion (GO:0005739), membrane (GO:0016020), extracellular exosome (GO:0070062)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
macromolecule localization1
response to chemical1
transition metal ion binding1
protein binding1
binding1
cytoplasm1
intracellular membrane-bounded organelle1
cellular anatomical structure1
extracellular vesicle1

Protein interactions and networks

STRING

971 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CUTACUTCQ9NTM9736
CUTAHSPE1P61604727
CUTASYNGAP1Q96PV0578
CUTATAX1BP3O14907547
CUTABACE1P56817507
CUTAHSPD1P10809474
CUTAPHF1O43189474
CUTAWASHC4Q2M389435
CUTAGABRB1P18505410
CUTAUBAC1Q9BSL1410
CUTAWDR46O15213405
CUTAPFDN6O15212373
CUTAAPEHP13798368
CUTAA0A1W2PPA2A0A1W2PPA2368
CUTANXNQ6DKJ4365

IntAct

22 interactions, top by confidence:

ABTypeScore
FBLIM1CUTApsi-mi:“MI:0915”(physical association)0.740
CUTAFBLIM1psi-mi:“MI:0915”(physical association)0.740
CUTAPRKAG1psi-mi:“MI:0914”(association)0.530
NR4A1CUTApsi-mi:“MI:0915”(physical association)0.520
CPLX3CUTApsi-mi:“MI:0915”(physical association)0.400
CUTAMLH1psi-mi:“MI:0915”(physical association)0.370
SOD1NPEPPSL1psi-mi:“MI:0914”(association)0.350
CUTAUBBpsi-mi:“MI:0914”(association)0.350
FBLIM1ILVBLpsi-mi:“MI:0914”(association)0.350
CUTAERI3psi-mi:“MI:0914”(association)0.350
VHLCUTApsi-mi:“MI:0915”(physical association)0.000
PINX1CUTApsi-mi:“MI:0915”(physical association)0.000
MCCCUTApsi-mi:“MI:0915”(physical association)0.000
GRB2CUTApsi-mi:“MI:0915”(physical association)0.000
CUTANR4A1psi-mi:“MI:0915”(physical association)0.000
tolCCUTApsi-mi:“MI:0915”(physical association)0.000
CUTApsi-mi:“MI:0915”(physical association)0.000
CUTAmappsi-mi:“MI:0915”(physical association)0.000
aguACUTApsi-mi:“MI:0915”(physical association)0.000

BioGRID (65): FBLIM1 (Two-hybrid), CUTA (Co-fractionation), PXDNL (Co-fractionation), CUTA (Affinity Capture-MS), CUTA (Affinity Capture-MS), UPP1 (Affinity Capture-MS), PRKAA1 (Affinity Capture-MS), CLTCL1 (Affinity Capture-MS), UBB (Affinity Capture-MS), PRKAB1 (Affinity Capture-MS), GID4 (Affinity Capture-MS), ARMC8 (Affinity Capture-MS), ZER1 (Affinity Capture-MS), PRKAG1 (Affinity Capture-MS), PDIA5 (Affinity Capture-MS)

ESM2 similar proteins: A0JPF9, A4D126, D2GU20, E1BCH6, E9PYK3, O35465, O60888, O75425, O75808, P43896, P47823, P69678, P97812, Q0VC80, Q13144, Q14318, Q27J81, Q2VPK5, Q3B7U9, Q3TX08, Q3U269, Q496Y0, Q499R4, Q5ND52, Q5RJG7, Q5S6T3, Q64350, Q66KY3, Q6MGD0, Q6ZT62, Q7T0X7, Q7T3C3, Q86U90, Q8BGG6, Q8BYH7, Q8CHW4, Q8HXH0, Q8IYL2, Q91YR5, Q96EN8

Diamond homologs: A4TRR5, A7FN06, A7ZV06, A8A7N3, A8AMR3, A9QYQ6, B1ITR1, B1JMR6, B1LQF8, B1XD17, B2K1X9, B2TY12, B4T2N5, B4TF74, B4TSC0, B5BKE7, B5F2K4, B5FRJ6, B5QZZ9, B5R985, B5Z2E7, B6I609, B7LBZ6, B7M8P8, B7MKU2, B7MSF8, B7NG75, B7NTJ6, C5A1C9, O28301, O58720, O60888, P69488, P69489, P69678, P93009, Q0SXE2, Q0T9Q4, Q109R6, Q1C0X5

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

46 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance31
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

874 predictions. Top by Δscore:

VariantEffectΔscore
6:33416772:CAGAA:Cacceptor_gain1.0000
6:33417249:A:ACdonor_gain1.0000
6:33417250:C:CCdonor_gain1.0000
6:33417250:CATGG:Cdonor_gain1.0000
6:33416773:AGAA:Aacceptor_gain0.9900
6:33416774:GAA:Gacceptor_gain0.9900
6:33416777:C:CCacceptor_gain0.9900
6:33417091:TCTCA:Tdonor_loss0.9900
6:33417093:TCA:Tdonor_loss0.9900
6:33417096:C:CTdonor_loss0.9900
6:33417138:CATAG:Cacceptor_gain0.9900
6:33417140:TAG:Tacceptor_gain0.9900
6:33417143:C:CAacceptor_loss0.9900
6:33417143:C:CCacceptor_gain0.9900
6:33417244:GAC:Gdonor_loss0.9900
6:33417245:ACT:Adonor_loss0.9900
6:33417246:CT:Cdonor_loss0.9900
6:33417247:TCAC:Tdonor_loss0.9900
6:33417248:CACAT:Cdonor_loss0.9900
6:33417249:A:AGdonor_loss0.9900
6:33417250:C:Tdonor_loss0.9900
6:33417250:CA:Cdonor_gain0.9900
6:33417250:CATG:Cdonor_gain0.9900
6:33417306:CGGCC:Cacceptor_gain0.9900
6:33417670:C:CTacceptor_gain0.9900
6:33417670:C:Tacceptor_gain0.9900
6:33417671:A:Tacceptor_gain0.9900
6:33416775:AACTA:Aacceptor_loss0.9800
6:33416777:C:Tacceptor_loss0.9800
6:33416778:T:Aacceptor_loss0.9800

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1001093191 (6:33419095 G>C), RS1002716361 (6:33418485 G>T), RS1004492886 (6:33416085 G>A), RS1004624786 (6:33420017 C>CTCG), RS1006019701 (6:33418392 G>T), RS1007878051 (6:33417692 A>G), RS1009250484 (6:33418436 G>T), RS1010489520 (6:33417317 T>A), RS1010586011 (6:33418622 C>T), RS1010700519 (6:33418304 C>T), RS1011571867 (6:33416156 C>G,T), RS1011624341 (6:33416416 T>C), RS1012316140 (6:33417766 C>G,T), RS1013339851 (6:33419658 T>C,G), RS1013582120 (6:33416163 C>T)

Disease associations

OMIM: gene MIM:616953 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

5 associations (top):

StudyTraitp-value
GCST004521_251Autism spectrum disorder or schizophrenia6.000000e-12
GCST004521_287Autism spectrum disorder or schizophrenia5.000000e-08
GCST004521_75Autism spectrum disorder or schizophrenia8.000000e-10
GCST005951_153Body mass index5.000000e-09
GCST007656_5Chronic obstructive pulmonary disease or resting heart rate (pleiotropy)3.000000e-15

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004340body mass index

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL6067022 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

31 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aaffects expression, decreases expression, decreases methylation, increases expression4
(+)-JQ1 compounddecreases expression3
Arsenicaffects methylation, increases methylation2
aristolochic acid Iincreases expression1
sodium arsenitedecreases expression1
cobaltous chloridedecreases expression1
isobutyl alcoholaffects cotreatment, decreases expression, increases abundance1
CGP 52608affects binding, increases reaction1
K 7174decreases expression1
ICG 001increases expression1
bisphenol Sincreases expression1
bisphenol AFincreases expression1
Sunitinibincreases expression1
Aminoglutethimidedecreases expression1
Benzo(a)pyreneaffects methylation1
Cadmiumincreases abundance, increases expression1
Dimethyl Sulfoxideaffects expression1
Doxorubicinaffects expression1
Gasolineincreases abundance, affects cotreatment, decreases expression1
Hydrogen Peroxideaffects expression1
Polycyclic Aromatic Hydrocarbonsdecreases expression, increases abundance, affects cotreatment1
Smokedecreases expression1
Tobacco Smoke Pollutionaffects expression1
Tretinoindecreases expression1
Zearalenonedecreases expression1
Cyclosporinedecreases expression1
Aflatoxin B1decreases methylation1
Antirheumatic Agentsincreases expression1
Cadmium Chlorideincreases abundance, increases expression1
Genisteindecreases expression1

ChEMBL screening assays

1 unique, capped per target: 1 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL5651226BindingBinding affinity to human CUTA incubated for 45 mins by Kinobead based pull down assayNVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.